Amarin

Amarin is a biopharmaceutical company focused on cardiovascular health, developing and commercializing therapeutics to reduce cardiovascular risk. Its lead product is Vascepa, a prescription omega-3 fatty acid capsule indicated to lower triglyceride levels in adults when used with diet, with development efforts including the REDUCE-IT program for patients with high triglycerides on statin therapy. The firm concentrates on lipid science and the therapeutic benefits of polyunsaturated fatty acids. It markets products primarily through wholesalers and specialty pharmacies via direct sales and maintains collaborations, including a development partnership with Mochida Pharmaceutical Co. Ltd. for products based on the active omega-3 ingredient in Vascepa. The company is headquartered in Dublin, Ireland, with research and development activities in Mystic, Connecticut, and was established in 1989 after formerly being named Ethical Holdings plc.